Abstract
MARFAN syndrome is an inherited disorder of connective tissue manifested in the ocular, skeletal and cardiovascular systems. It is inherited as an autosomal dominant with high penetrance, but has great clinical variability1. Linkage studies have mapped the Marfan locus to chromosome 15q 15–21.3 (refs 2, 3). There have been no reports of genetic heterogeneity in the syndrome. Following the identification of fibrillin (a glycoprotein component of the extracellular microfibril4), immunohistopathological quantification of the protein in skin and fibroblast culture5, and examination of fibrillin synthesis, extracellular transport, and incorporation into the extracellular matrix (D. M. Milewicz, R.E.P., E. S. Crawford and P. H. Byers, manuscript in preparation) have demonstrated abnormalities of fibrillin metabolism in most patients. A portion of the complementary DNA encoding fibrillin has been cloned6 and mapped by in situ hybridization to chromosome 15 (ref. 7). Here we report that the fibrillin gene is linked to the Marfan phenotype (θ =0.00; logarithm of the odds (lod) = 3.9) and describe a de novo missense mutation in the fibrillin gene in two patients with sporadic disease. We thus implicate fibrillin as the protein defective in patients with the Marfan syndrome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pyeritz, R. E. & McKusick, V. A. New Engl. J. Med. 300, 772–777 (1977).
Kainulainen, K. et al. New Engl. J. Med. 323, 935–939 (1990).
Dietz, H. C. et al. Genomics 9, 355–361 (1991).
Sakai, L. Y., Keene, D. R. & Engvall, E. J. Cell. Biol. 103, 2499–2509 (1986).
Hollister, D. W., Godgrey, M., Sakai, L. Y. & Pyeritz, R. E. N. Engl. J. Med. 323, 152–159 (1990).
Maslen, C. L. et al. Nature 352, 334–337 (1991).
Magenis, R. E. et al. Genomics (in the press).
Boudoulas, H. & Wooley, C. F. in Mitral Valve Prolapse and the Mitral Valve Prolapse Syndrome (eds Boudoulas, H. & Wooley, C. F.) 161–167 (Futura, Mount Kisco, 1988).
Weber, J. L. & May, P. E. Am. J. hum. Genet. 44, 388–396 (1989).
Weber, J. L. & May, P. E. Nucleic Acids Res. 18, 4640 (1990).
Weber, J. L. & May, P. E. Nucleic Acids Res. 18, 2202 (1990).
Weber, J. L. & May, P. E. Nucleic Acids Res. 18, 4637 (1990).
Kelley, M. R. et al. Cell 51, 539–548 (1987).
Higuchi, M. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
Higuchi, M. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
Byers, P. H. Trends Genet. 6, 293–300 (1990).
Den Dunnen, J. Y. et al. Nature 329, 640–642 (1987).
Forrest, S. M. et al. Nature 329, 638–640 (1987).
Nakamura, Y. et al. Genomics 3, 342–346 (1988).
Donis-Keller, H. et al. Cell 51, 319–337 (1987).
Sambrook, J., Fritsch, E. F. & Maniatis, T. in Molecular Cloning 2nd edn (Cold Spring Harbor Laboratory Press, 1989).
Orita, M. et al. Genomics 5, 874–879 (1989).
Saiki, R. L. et al. New Engl. J. Med. 319, 537–541 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dietz, H., Cutting, C., Pyeritz, R. et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352, 337–339 (1991). https://doi.org/10.1038/352337a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/352337a0
